News | September 17, 2025
ProBioGen to spearhead GMP manufacturing at Berlin’s gene & cell therapy hub
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
ProBioGen will oversee the design, construction, and operation of the 4,600-square-meter GMP manufacturing unit
NouvNeu001 is the world’s first allogeneic iPSC-derived cell therapy for Parkinson’s disease to receive this designation
Biocytogen will provide proprietary, fully human antibodies derived from its RenMice platform for evaluation in Merck’s antibody-conjugated LNP services
Replicate will receive research funding and could potentially receive up to approximately US$550 million
This strategic investment strengthens Cohance's integrated oligonucleotide platform
The partnership aims to co-develop technologies set to revolutionize manufacturing of plasmid DNA (pDNA), a critical raw material for advanced medicines
His experience includes leadership roles in manufacturing, strategic management, and commercial operations across the pharmaceuticals, healthcare, and specialty chemicals sectors
AMPLIFY Phase III trial results demonstrated statistically significant and clinically meaningful improvement in progression-free survival for Calquence combinations
Ideal for extreme dry skin and hyperkeratotic conditions such as psoriasis and ichthyosis, Ureaderm offers the next step in evidence-based, effective skin hydration
Subscribe To Our Newsletter & Stay Updated
